$21.00
00.00%
Pre-Market: 4:00 PM EDT
15 minutes delayed
Contineum Therapeutics
CTNMNASDAQ
Contineum Therapeutics (NASDAQ:CTNM) Stock, Earnings Estimates, EPS, And Revenue
Contineum Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Jul 30
EPS Estimate
$-0.350
Quarterly Revenue Estimate
–
Annual Revenue
(as of Mar 31)
(as of Mar 31)
$50M
Analyze the earnings history of Contineum Therapeutics using advanced sorting and filters.
Contineum Therapeutics (CTNM) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
Contineum Therapeutics (CTNM) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
FAQ
When is Contineum Therapeutics (NASDAQ:CTNM) reporting earnings?
Contineum Therapeutics (CTNM) is scheduled to report earnings on August 16, 2024. The last reported earnings were for reported on May 16, 2024 for Q1.
What were the latest earnings per share (EPS) for Contineum Therapeutics (NASDAQ:CTNM)?
The Actual EPS was $-3.55, which missed the estimate of $0.00.
What were Contineum Therapeutics’s (NASDAQ:CTNM) revenues?
The Actual Revenue was $0K, which hit the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.